A Safety and Efficacy Evaluation Study of Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC
Latest Information Update: 25 Dec 2024
At a glance
- Drugs Adebrelimab (Primary) ; Carboplatin (Primary) ; Irinotecan (Primary) ; Etoposide
- Indications Small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 25 Dec 2024 New trial record